Current Challenges and Unmet
Needs in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
2.Paradigm Shift in Post-CCRT
Consolidation Therapy -Evolving role of immune
checkpoint inhibitors (ICIs) as consolidation therapy post-CCRT in LS-SCLC. 3.Safety Profile, Toxicity
Management, and Adverse Event Mitigation -Evaluating the safety and
tolerability of consolidation immunotherapy after definitive CCRT. In-class Difference in COPD
Triple Therapy:Efficacy, Safety, Patient Friendly Chronic Obstructive Pulmonary
Disease (COPD) is a common, progressive, and preventable inflammatory lung
condition characterized by persistent airflow limitation. Long-term exposure to
harmful particles or gases causes chronic inflammation in the airways and
destruction of lung parenchyma, leading to narrowed airways and reduced lung
elasticity. Key Symptoms and Etiology The primary symptoms of COPD
include chronic cough, sputum production, chest tightness, and progressive
exertional dyspnea (shortness of breath). The leading risk factor is cigarette
smoking (including second-hand smoke), along with occupational dust exposure,
air pollution, and advanced age. Treatment and Management
Strategy While COPD is a non-curable
condition, structured clinical management can effectively alleviate symptoms,
reduce exacerbation risks, and improve health-related quality of life: Smoking Cessation: The single
most effective intervention to slow down lung function decline. Inhaled Maintenance Therapy:
Utilizing bronchodilators or combination therapies (including inhaled
corticosteroids) to maintain airway patency and control airway inflammation. Pulmonary Rehabilitation
& Vaccination: Engaging in exercise training and receiving annual influenza
and pneumococcal vaccines to prevent respiratory infections and exacerbations.
-In-depth analysis of key
clinical trial evidence (e.g., ADRIATIC trial) evaluating survival outcomes,
durable responses, and systemic disease control.
-Practical considerations for
identifying and managing immune-related adverse events (irAEs) and
radiation-induced pneumonitis in clinical practice.
| 時間 | 主題 | |
|---|---|---|
| 沒有資料 | ||